Cargando…
FRI547 Orbital Surgery In Moderate-To-Severe Graves´Ophthalmopathy: Institutional Experience
Disclosure: L. Delfino: None. Z. Anabela: None. V. Ilera: None. V. García Roel: None. A. Reyes: None. A.T. Gauna: None. Management of moderate-to-severe Graves´ophtalmopathy (GO) depends mainly on the degree of soft tissue inflammation. While immunosuppressive therapy is indicated in the active phas...
Autores principales: | Delfino, Laura, Anabela, Zunino, Ilera, Veronica, García Roel, Valeria, Reyes, Adriana, Teresa Gauna, Alicia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555276/ http://dx.doi.org/10.1210/jendso/bvad114.1892 |
Ejemplares similares
-
Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves’ disease
por: Delfino, Laura Carolina, et al.
Publicado: (2017) -
FRI553 ICI-induced Thyroid Ophthalmopathy With De Novo Graves’ Disease
por: Moctezuma, Sananda I, et al.
Publicado: (2023) -
FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2023) -
The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021) -
ODP533 Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)